|
gptkbp:instanceOf
|
company
|
|
gptkbp:acquisition
|
gptkb:Roxon_Energy_Corporation
none
|
|
gptkbp:associatedWith
|
gptkb:Spider-Man
|
|
gptkbp:brand
|
high
|
|
gptkbp:businessModel
|
B2B_and_B2C
|
|
gptkbp:CEO
|
gptkb:Norman_Osborn
|
|
gptkbp:collaborations
|
universities
|
|
gptkbp:community
|
controversial
|
|
gptkbp:communityEngagement
|
local outreach programs
|
|
gptkbp:communityImpact
|
significant
|
|
gptkbp:communityPartnerships
|
strategic alliances
|
|
gptkbp:competitors
|
Alchemax
|
|
gptkbp:controversy
|
ethical concerns
|
|
gptkbp:corporateSocialResponsibility
|
active
|
|
gptkbp:culturalHeritage
|
innovative
|
|
gptkbp:customerBase
|
pharmaceutical companies
|
|
gptkbp:customerFeedback
|
positive
|
|
gptkbp:employees
|
5000
competitive
|
|
gptkbp:financialPerformance
|
strong
|
|
gptkbp:foundedBy
|
gptkb:Norman_Osborn
|
|
gptkbp:future_plans
|
advanced
|
|
gptkbp:futurePlans
|
new product lines
|
|
gptkbp:hasResearchInterest
|
extensive
|
|
gptkbp:headCoach
|
gptkb:Dr._Curt_Connors
|
|
gptkbp:headquarters
|
gptkb:New_York_City
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Oscorp Biotech
|
|
gptkbp:industry
|
biotechnology
|
|
gptkbp:innovation
|
cutting-edge technology
|
|
gptkbp:investmentFocus
|
transparent
biomedical research
|
|
gptkbp:keyFigures
|
biotech drugs
|
|
gptkbp:leadership
|
diverse
|
|
gptkbp:legalStatus
|
lawsuits
|
|
gptkbp:market
|
$10 billion
global
|
|
gptkbp:marketSegment
|
aggressive
|
|
gptkbp:notableEvent
|
Goblin_Serum
|
|
gptkbp:notableFeature
|
gptkb:Harry_Osborn
|
|
gptkbp:parentCompany
|
gptkb:Oscorp_Industries
|
|
gptkbp:partnerships
|
government contracts
|
|
gptkbp:patentCitation
|
genetic engineering technologies
|
|
gptkbp:philanthropy
|
gptkb:Osborn_Foundation
|
|
gptkbp:products
|
genetic research
|
|
gptkbp:researchFocus
|
genetic mutations
|
|
gptkbp:researchInterest
|
$200 million
numerous
|
|
gptkbp:revenue
|
$1 billion
|
|
gptkbp:riskManagement
|
proactive
|
|
gptkbp:socialMedia
|
active presence
|
|
gptkbp:strategicGoals
|
expansion
|
|
gptkbp:subsidiary
|
gptkb:Oscorp_Pharmaceuticals
|
|
gptkbp:supplyChain
|
efficient
global network
|
|
gptkbp:sustainabilityInitiatives
|
green technology
|
|
gptkbp:trademark
|
gptkb:Oscorp_logo
|
|
gptkbp:training
|
ongoing
|